2023-09-18 Vocabulary WG Meeting Notes
- Anonymous
- r.dash
- riki.merrick
Participants for today’s call:
Membership:
Name | Organization | Role |
|---|---|---|
Scott Campbell | UNMC | Co-Chair Steering Committee member |
Raj Dash | College of American Pathologists (CAP) | Co-Chair Steering Committee member |
Dan Rutz | Epic | Steering Committee member |
Muktha Natrajan | CDC |
|
Sandy Jones (Secondary) | CDC Cancer Surveillance |
|
Anne Peruski (Secondary) | CDC |
|
Andrea Pitkus | University of Wisconsin-Madison | Steering Committee member |
Xavier Gansel | bioMérieux | Steering Committee member |
Stan Huff | Graphite Health | Steering Committee member |
John Snyder | NLM | Steering Committee member |
Rob Hausam | Hausam Consulting |
|
Marjorie Rollins | Regenstrief | Steering Committee member |
Amy McCormick (secondary) | Epic |
|
Nanguneri Nirmala | Tufts Medical Center | Steering Committee member |
Mehdi Nassiri | Indiana University/Indiana University Health/Association for Molecular Pathology | Steering Committee member |
Eza Hafeza | Regenstrief | Steering Committee member |
Jim Case | Snomed International | Steering Committee member |
Mary Kennedy | CAP |
|
++++
Discussion topics
Item | Notes |
|---|---|
Identify tangible activities for this working group | Identify use cases / challenges in lab interoperability LOINC was never intended to be the sole solution for lab data interoperability. Units of measure is an example (not explicit in a vocabulary standard, LOINC or SCT) so additional elements necessary for interoperability. LOINC allows post coordination of methods. Instruments, devices and reagents will not be incorporated. So need different (standardized) mechanism. Education on best practices for implementing standards (vocab, transport, etc) could be a deliverable of this group. Could send out a poll to identify gaps that need to be addressed to support semantic interoperability. Specimen Type and Source is another challenge for many. Also pre/pos coord recommendations, etc. And what to do when a IVD test doesn't distinguish to a single org (A or B, but can't tell which). and mapping these. Examples / use cases:
Previously suggested efforts to focus on: project around result codes - qualitative (all lab domains), given priority of 1 (Make recommendations regarding use of terminology for results…align HL7/LAW) project around result codes - micro-organism (gram stain, rod/cocci) project around result codes - AST project around result codes - microscopic and culture observations Specimen CMT content / adoption surgical synoptic reporting Anatomic Pathology Structured Reporting (cancer pathology) Structured genomics reporting (WGS, biomarkers, etc.) Test naming conventions
What is the expected outcome of the group and timeline? Good vs. Grand focus? URU principle |
|
|
Cloud recording: 2023_09_18_SHIELD_StandardWG_Zoom.zip
Video Conferencing, Web Conferencing, Webinars, Screen Sharing
From Chat:
00:05:48 Rajesh Dash: https://aphlinformatics.atlassian.net/wiki/spaces/SC/pages/2034860113
00:09:06 Andrea Pitkus: Sounds like the misinformation needs to be addressed as it continues to circulate
00:10:04 Andrea Pitkus: Perhaps education on Best Practices that Communications WG can take up once decided by SHIELD
00:15:51 Riki Merrick | Vernetzt / APHL: As usual, I will have to drop at the bottom of the hour - sorry about that
00:16:27 Andrea Pitkus: Specimen Type and Source is another challenge for many. Also pre/pos coord recommendations, etc.
00:16:54 Andrea Pitkus: Organisms / SCT precoord/post coord (and depending which IG).
00:17:33 Andrea Pitkus: And what to do when a IVD test doesn't distinguish to a single org (A or B, but can't tell which). and mapping these.
00:20:17 Xavier Gansel: mics is not working properly, I can only listen & chat ;-)
00:21:45 Rajesh Dash: 2023-09-18 Vocabulary WG Meeting Notes
00:26:20 Xavier Gansel: CMT should be one of the three :-)
00:26:36 Andrea Pitkus: https://aphlinformatics.atlassian.net/wiki/download/attachments/1887437089/Shield Project Report Biomerieux 28Mar23.docx?api=v2
00:27:01 Rajesh Dash: https://aphlinformatics.atlassian.net/wiki/download/attachments/1887437089/Shield Project Report Biomerieux 28Mar23.docx?api=v2
00:27:29 Riki Merrick | Vernetzt / APHL: Working Groups
00:28:01 Rajesh Dash: Scott is host now
00:28:34 Amy McCormick: I have to drop early as well.
00:29:31 Riki Merrick | Vernetzt / APHL: Specimen CMT will need another 2 months I think to be fully ready for sharing, but happy to write up the project document and also give an intro to the topic
00:29:42 Riki Merrick | Vernetzt / APHL: Gotta go for now - bye!
00:36:44 Xavier Gansel: sorry, PC crached
00:37:28 Xavier Gansel: Gram results / manual ID results
00:37:43 Andrea Pitkus: Reacted to "Gram results / manua..." with 👍
00:37:45 Xavier Gansel: Gram+, cocobacil G+, ettc.
00:38:10 Xavier Gansel: then also put SNOMED codes in from on HL7 results codes
00:38:33 Xavier Gansel: make those an authoritative source
00:38:55 Xavier Gansel: once included in HL7 / IHE LAW specs
00:39:04 Xavier Gansel: or similar
00:39:38 Xavier Gansel: yes
00:39:56 Xavier Gansel: see IHE LAW table 0078
00:40:33 Xavier Gansel: transelate the table in SNOMED and we have a good low hangging fruit
00:44:32 Xavier Gansel: lol
00:45:22 Andrea Pitkus: I like qualitative result values from micro then across chem/immunology, etc
00:45:54 Andrea Pitkus: Also items than impact PH, common lab items
00:46:25 Andrea Pitkus: URU for the notes
00:46:27 Xavier Gansel: any thing we could push into international specs would be useful : see HL7 / IHE and similar specs
00:46:36 Andrea Pitkus: Reacted to "any thing we could p..." with 👍
00:47:38 Andrea Pitkus: Perhaps pick something that can be done by next july to show progress?
00:49:33 Nanguneri Nirmala: Reacted to "Perhaps pick somethi..." with 👍
00:52:17 Andrea Pitkus: FHIR mCode has LOINC codes in the Biomarker/Tumor Marker value sets.
00:52:42 Andrea Pitkus: SO Oncology/ASCO are using that. so we need to work through these discussions to achieve interoperability.
00:52:47 Dan Rutz: In terms of work to do, I would vote for the area involving result test codes and interoperability/interchangeability.
00:54:43 Andrea Pitkus: Reacted to "In terms of work to ..." with 👍
00:58:39 Xavier Gansel: I have to drop